12 Health Care Stocks Moving In Thursday's After-Market Session
I'm LongbridgeAI, I can summarize articles.During Thursday's after-market session, several healthcare stocks experienced significant volatility. Lucid Diagnostics surged 41.9% to $0.46, while Aardvark Therapeutics rose 19.74% to $4.73. Other gainers included Geovax Labs, NeuroOne Medical Tech, PAVmed, and Estrella Immunopharma. Conversely, Scinai Immunotherapeutics fell 7.7%, Artiva Biotherapeutics dropped 6.46%, and Longeveron declined 6.3%. Beyond Air, Elicio Therapeutics, and Valion Bio also saw decreases.
Gainers
- Lucid Diagnostics (NASDAQ:LUCD) stock moved upwards by 41.9% to $0.46 during Thursday's after-market session. The company's market cap stands at $67.1 million.
- Aardvark Therapeutics (NASDAQ:AARD) stock increased by 19.74% to $4.73. The market value of their outstanding shares is at $85.3 million.
- Geovax Labs (NASDAQ:GOVX) stock moved upwards by 8.13% to $0.23. The market value of their outstanding shares is at $1.1 million.
- NeuroOne Medical Tech (NASDAQ:NMTC) shares moved upwards by 7.14% to $1.05. The company's market cap stands at $8.9 million.
- PAVmed (NASDAQ:PAVM) stock rose 6.82% to $2.19. The company's market cap stands at $21.9 million.
- Estrella Immunopharma (NASDAQ:ESLA) shares increased by 6.41% to $0.77. The company's market cap stands at $17.3 million.
Losers
- Scinai Immunotherapeutics (NASDAQ:SCNI) shares decreased by 7.7% to $0.56 during Thursday's after-market session.
- Artiva Biotherapeutics (NASDAQ:ARTV) stock declined by 6.46% to $5.8. The company's market cap stands at $320.7 million.
- Longeveron (NASDAQ:LGVN) shares declined by 6.3% to $1.49. The company's market cap stands at $4.7 million.
- Beyond Air (NASDAQ:XAIR) stock declined by 5.83% to $2.1. The market value of their outstanding shares is at $2.1 million.
- Elicio Therapeutics (NASDAQ:ELTX) stock declined by 5.16% to $1.84. The market value of their outstanding shares is at $41.2 million.
- Valion Bio (NASDAQ:VBIO) stock declined by 4.83% to $0.91. The market value of their outstanding shares is at $1.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to unlock923characters for free
Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.